AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2022
Feb 15, 2022
30136_dirs_2022-02-15_282d4e48-cf39-420f-adea-14581f4fc782.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2022-02-11
Reporting Person: Nelson Lisa M (President-International)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-11 | Common Stock | A | 1445.0000 | $0.0000 | Acquired | 9754.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | Stock Option/Right to Buy | $225.0000 | A | 5772.0000 | Acquired | 2032-02-11 | Common Stock (5772.0000) | Direct |
Footnotes
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Registration Form
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26